1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as Edg receptor agonists
A Standard patent application filed on 16 June 2003 credited to Lynch, Christopher L.
;
Hale, Jeffrey J.
;
Li, Zhen
;
Chen, Weirong
;
Neway, William E. III
;
Mills, Sander G.
Details
Application number :
2003276043
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as Edg receptor agonists
Inventor :
Lynch, Christopher L.
;
Hale, Jeffrey J.
;
Li, Zhen
;
Chen, Weirong
;
Neway, William E. III
;
Mills, Sander G.
Agent name :
Spruson & Ferguson
Address for service :
Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Australia
Filing date :
16 June 2003
Associated companies :
Applicant name :
Merck & Co., Inc.
Applicant address :
126 East Lincoln Avenue Rahway NJ 07065-0907 United States of America